GRI Bio

GRINasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$2.603 M

$1.47 -5.16%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$12.0M

Loss-making

Shares outstanding

1,770,838

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#489CDT EquityCDT$2.69M
#490Sunshine BiopharmaSBFM$2.61M
#491GRI BioGRI$2.60M
#492Artelo BiosciencesARTL$2.51M
#493OragenicsOGEN$2.48M

Where these numbers come from

Share counts and financials for GRI Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.